Home
October 2009 November 2009 December 2009
Su Mo Tu We Th Fr Sa
Week 45 1 2 3 4 5 6 7
Week 46 8 9 10 11 12 13 14
Week 47 15 16 17 18 19 20 21
Week 48 22 23 24 25 26 27 28
Week 49 29 30

Assessment of Urodynamic and Detrusor Contractility Variables in Patients With Overactive Bladder Syndrome Treated With Botulinum Toxin-A: Is Incomplete Bladder Emptying Predictable? - Abstract Show Comments PDF Print E-mail
  
Wednesday, 26 November 2008

Department of Urology, Guy's Hospital & KCL School of Medicine, London.

To assess whether incomplete bladder emptying and the need for clean intermittent self-catheterization (CISC) is predictable, by analysing urodynamic and detrusor contractility variables in patients treated with botulinum toxin-A (BTX-A) for refractory idiopathic detrusor overactivity (IDO).

Sixty-seven patients (mean age 50.3) with IDO, from two centres, had bladder injections of 200 U BTX-A. Patients with difficulty in emptying their bladder and/or persistent overactive bladder symptoms, with postvoid residual volumes (PVR) of >150 mL after treatment were started on CISC. Urodynamics were conducted at baseline, 4 and 12-16 weeks after injection with BTX-A. Detrusor contractility was assessed using the projected isovolumetric pressure (PIP1) in women and bladder contractility index (BCI) in men.

There were improvements in the mean maximum cystometric capacity, bladder compliance and maximum detrusor pressures during filling cystometry after BTX-A injections. The PVR was significantly increased at 4 but not at 12 weeks. Nineteen patients required CISC and when compared with those not needing CISC their pretreatment maximum flow rate (15 vs 22 mL/s, P = 0.003), PIP1 (43 vs 58, P = 0.02) and BCI (113 vs 180, P = 0.001) were lower. Receiver operator characteristic curve analysis suggested that a PIP1 of < /=50 in women (sensitivity 0.83; specificity 0.70; area under the curve 0.822) and BCI < /=120 (sensitivity 0.7; specificity 0.79; area 0.879) might predict the need for CISC.

The maximum flow rate, PIP1 and BCI were significantly lower in patients who required CISC after BTX-A treatment than in those who did not. A PIP1 of < /=50 in women and a BCI of < /=120 might be predictive of a need for CISC in this setting, and might help when counselling patients.

Written by:
Sahai A, Sangster P, Kalsi V, Khan MS, Fowler CJ, Dasgupta P.   Are you the author?

Reference:
BJU Int. 2008 Oct 16. Epub ahead of print.

PubMed Abstract
PMID:18990156

 

UroToday.com Overactive Bladder (OAB) Section

 

Reader Comments

Please log-in or register in order to submit comments.

Powered by AkoComment!

 
User Rating: / 1
PoorBest


 
Visitor Ratings:
Healthcare Professionals:
5 (1 votes)


Bookmark and Share

Member's Section

Login

Sign Up

Quick Search

Featured Conference

Media and Publisher

Advertising Rates
Reprints

Working with Industry

Case Studies
Sponsorship Opportunities

Overactive Bladder
Sponsored By